Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BY-NC 4.0Medicine

Association between triglyceride-glucose body mass index and future risk of arthritis in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: A national prospective cohort study

  1. 1Department of Acupuncture and Moxibustion, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
  2. 2School of Acupuncture, Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China.

Abstract

Cardiovascular-kidney-metabolic (CKM) syndrome encompasses interrelated cardiovascular, renal and metabolic disorders. Arthritis is linked to CKM multimorbidity, but the association between triglyceride-glucose body mass index (TyG-BMI), a surrogate marker of insulin resistance and incident arthritis across the CKM spectrum remains unclear. We analyzed data from the CHARLS cohort, including 5018 participants aged ≥45 years with CKM stages 0 to 3. Analytical approaches included multivariable logistic regression, restricted cubic splines, stratified and mediation analyses. Incident arthritis was defined by self-reported physician diagnosis, without confirmation via medical records. During follow-up, 2307 participants (45.97%) developed incident arthritis. Each one-standard-deviation increase in triglyceride-glucose body mass index (triglyceride-glucose body mass index) was associated with an 11% higher risk of arthritis (odds ratio [OR] = 1.11, 95% confidence interval [CI]: 1.04–1.19), with an approximately linear positive dose-response trend. The association appeared stronger in participants with sleep duration <7 hours (OR = 1.19, 95% CI: 1.08–1.31) and those at CKM stage 1 (OR = 1.57, 95% CI: 1.20–2.05). Exploratory mediation analyses suggested negative mediating roles of HDL-C and, marginally, BUN. Triglyceride-glucose body mass index exhibited an independent positive association with incident arthritis across CKM stages 0 to 3 and may serve as a practical indicator for early risk stratification.

Related

  1. Comparison analysis of the triglyceride-glucose index, triglyceride-glucose and frailty index in cardiovascular disease and mortality association among patients with rheumatoid arthritis: A population-based cohort study.
    Yangyu Xu, Hong Zhao, Yuxiang Gao +4
    MedicinePeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
  2. Association of sleep time with all-cause and cardiovascular mortality among individuals with advanced cardiovascular-kidney-metabolic syndrome : A NHANES-based prospective cohort study
    Yangyang Xiong, Yue Yin, Jing Wang +3
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Association of Homocysteine With All-Cause and Cardiovascular Mortality in Individuals With Advanced Cardiovascular-Kidney-Metabolic Syndrome: A Nationwide Prospective Cohort Study
    Huifeng Shang, Xionghai Li, Xuewei Zhang +5
    Medical Science Monitor: International Medical Journal of Experimental and Clinical ResearchPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  4. Triglyceride-glucose index combined with DAS28-ESR predicts cardiovascular disease risk in patients with rheumatoid arthritis: a national multicenter cohort study
    Xie-li Ma, Tian Chang, Yu-chen Yang +8
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  5. Association of the triglyceride-glucose index with dynamic bidirectional transitions of cardiovascular-kidney-metabolic syndrome: a multistate Markov model study based on CHARLS
    Xiunan Liu, Buyuan Tian, Hongwei Leng +3
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{yan2026association,
  title = {{Association between triglyceride-glucose body mass index and future risk of arthritis in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: A national prospective cohort study}},
  author = {Haokun Yan and Yaojia Yang and Baixiao Zhao},
  journal = {Medicine},
  year = {2026},
  month = nov,
  doi = {10.1097/md.0000000000051396},
  url = {https://doi.org/10.1097/md.0000000000051396},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Association between triglyceride-glucose body mass index and future risk of arthritis in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: A national prospective cohort study
AU  - Haokun Yan
AU  - Yaojia Yang
AU  - Baixiao Zhao
PY  - 2026
DA  - 2026/11/06
JO  - Medicine
DO  - 10.1097/md.0000000000051396
UR  - https://doi.org/10.1097/md.0000000000051396
AB  - Cardiovascular-kidney-metabolic (CKM) syndrome encompasses interrelated cardiovascular, renal and metabolic disorders. Arthritis is linked to CKM multimorbidity, but the association between triglyceride-glucose body mass index (TyG-BMI), a surrogate marker of insulin resistance and incident arthritis across the CKM spectrum remains unclear. We analyzed data from the CHARLS cohort, including 5018 participants aged ≥45 years with CKM stages 0 to 3. Analytical approaches included multivariable logistic regression, restricted cubic splines, stratified and mediation analyses. Incident arthritis was defined by self-reported physician diagnosis, without confirmation via medical records. During follow-up, 2307 participants (45.97%) developed incident arthritis. Each one-standard-deviation increase in triglyceride-glucose body mass index (triglyceride-glucose body mass index) was associated with an 11% higher risk of arthritis (odds ratio [OR] = 1.11, 95% confidence interval [CI]: 1.04–1.19), with an approximately linear positive dose-response trend. The association appeared stronger in participants with sleep duration <7 hours (OR = 1.19, 95% CI: 1.08–1.31) and those at CKM stage 1 (OR = 1.57, 95% CI: 1.20–2.05). Exploratory mediation analyses suggested negative mediating roles of HDL-C and, marginally, BUN. Triglyceride-glucose body mass index exhibited an independent positive association with incident arthritis across CKM stages 0 to 3 and may serve as a practical indicator for early risk stratification.
SN  - 0025-7974
SN  - 1536-5964
ER  -